Tag results:
lymphocytes
Hematopoiesis News
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B Cell Lymphoma
[Vincerx Pharma, Inc.] Vincerx Pharma, Inc. announced that the European Commission has granted Orphan Drug Designation to VIP152, the Company’s PTEFb/CDK9 inhibitor, for the treatment of diffuse large B cell lymphoma.
Hematopoiesis News
Aberrant Chromatin Landscape Following Loss of the H3.3 Chaperone Daxx in Hematopoietic Precursors Leads to Pu.1-Mediated Neutrophilia and Inflammation
[Nature Cell Biology] The authors findings implicated retrotransposable element silencing in hematopoiesis and suggested a cross-talk between the H3.3 loading machinery and the pioneer transcription factor Pu.1.
Hematopoiesis News
miR-181a Is a Novel Player in the STAT3-Mediated Survival Network of TCRαβ+ CD8+ T Large Granular Lymphocyte Leukemia
[Leukemia] By using TL1, a human T-LGL cell line, the authors could show that miR-181a was an actor in T-LGL leukemia, driving STAT3 activation by SOCS3 inhibition and ERK1/2 phosphorylation by DUSP6 inhibition and verified this mechanism in an independent cell line.
Cell Therapy News
An NK-Like CAR T Cell Transition in CAR T Cell Dysfunction
[Cell] Researchers identified a gene signature defining CAR and TCR dysregulation and transcription factors, including SOX4 and ID3 as key regulators of CAR T cell exhaustion.
Cell Therapy News
Genetic Ablation of PRDM1 in Antitumor T Cells Enhances Therapeutic Efficacy of Adoptive Immunotherapy
[Blood] Scientists identified PR domain zinc finger protein 1 (PRDM1) i.e., Blimp-1, as a key epigenetic gene associated with terminal T cell differentiation.
Cell Therapy News
Natural Killer Cells and Immune-Checkpoint Inhibitor Therapy: Current Knowledge and New Challenges
[Molecular Therapy-Oncolytics] Scientists overview and discuss this new perspective, focusing on the most relevant candidates for this role among the variety of potential NK immune checkpoints.